Trial Profile
Open Label, Single-Center, Phase 1 Clinical Study to Evaluate the Safety and the Efficacy of PNEUMOSTEM Treatment in Premature Infants With Bronchopulmonary Dysplasia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Adverse reactions
- Sponsors Medipost
- 02 Dec 2013 Extension study details added.
- 30 Nov 2013 New trial record